Viewing Study NCT00591266


Ignite Creation Date: 2025-12-24 @ 4:01 PM
Ignite Modification Date: 2026-02-05 @ 9:06 AM
Study NCT ID: NCT00591266
Status: COMPLETED
Last Update Posted: 2011-07-22
First Post: 2007-12-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension
Sponsor: Takeda
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Blood pressure View
None blood pressure monitoring ambulatory View
None Drug Therapy View